Recombinant Saccharomyces cerevisiae serves as novel carrier for oral DNA vaccines in Carassius auratus

Fish and Shellfish Immunology

Volumn 47, Issue 2, 2015, Pages 758-765

  Yan, Nana ^a   Xu, Kun ^a   Li, Xinyi ^a   Liu, Yuwan ^a   Bai, Yichun ^a   Zhang, Xiaohan ^a   Han, Baoquan ^a   Chen, Zhilong ^a   Zhang, Zhiying ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Carassius auratus; DNA vaccine; Immune response; Oral delivery; Saccharomyces cerevisiae

Indexed keywords

DNA VACCINE; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; OVALBUMIN; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FISH DISEASES; GENETICS; GOLDFISH; IMMUNOLOGY; METABOLISM; SACCHAROMYCES CEREVISIAE; VETERINARY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FISH DISEASES; GOLDFISH; GREEN FLUORESCENT PROTEINS; OVALBUMIN; SACCHAROMYCES CEREVISIAE; VACCINES, DNA; VIRAL VACCINES;

EID: 84945564997     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2015.10.020     Document Type: Article

References (36)

1. Evensen O., Leong J.A. DNA vaccines against viral diseases of farmed fish. Fish Shellfish Immunol. 2013, 35:1751-1758.
2. Dhar A.K., Manna S.K., Thomas Allnutt F.C. Viral vaccines for farmed finfish. Virusdisease 2014, 25:1-17.
3. Rombout J.H., Yang G., Kiron V. Adaptive immune responses at mucosal surfaces of teleost fish. Fish Shellfish Immunol. 2014, 40:634-643.
4. Holvold L.B., Myhr A.I., Dalmo R.A. Strategies and hurdles using DNA vaccines to fish. Vet. Res. 2014, 45:21.
5. Tonheim T.C., Bogwald J., Dalmo R.A. What happens to the DNA vaccine in fish? a review of current knowledge. Fish Shellfish Immunol. 2008, 25:1-18.
6. Plant K.P., Lapatra S.E. Advances in fish vaccine delivery. Dev. Comp. Immunol. 2011, 35:1256-1262.
7. Vandenberg G.W. Oral vaccines for finfish: academic theory or commercial reality?. Anim. Health Res. Rev. 2007, 5:301-304.
8. Blanquet S., Marol-Bonnin S., Beyssac E., Pompon D., Renaud M., Alric M. The 'biodrug' concept: an innovative approach to therapy. Trends Biotechnol. 2001, 19:393-400.
9. Underhill D.M. Macrophage recognition of zymosan particles. J. Endotoxin Res. 2003, 9:176-180.
10. Blanquet S., Meunier J.P., Minekus M., Marol-Bonnin S., Alric M. Recombinant Saccharomyces cerevisiae expressing P450 in artificial digestive systems: a model for biodetoxication in the human digestive environment. Appl. Environ. Microbiol. 2003, 69:2884-2892.
11. Wansley E.K., Chakraborty M., Hance K.W., Bernstein M.B., Boehm A.L., Guo Z., et al. Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin. Cancer Res. 2008, 14:4316-4325.
12. Bernstein M.B., Chakraborty M., Wansley E.K., Guo Z., Franzusoff A., Mostbock S., et al. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine 2008, 26:509-521.
13. Breinig F., Heintel T., Schumacher A., Meyerhans A., Schmitt M.J. Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast. FEMS Immunol. Med. Microbiol. 2003, 38:231-239.
14. Heintel T., Breinig F., Schmitt M.J., Meyerhans A. Extensive MHC class I-restricted CD8 T lymphocyte responses against various yeast genera in humans. FEMS Immunol. Med. Microbiol. 2003, 39:279-286.
15. Walch B., Breinig T., Schmitt M.J., Breinig F. Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast. Gene Ther. 2012, 19:237-245.
16. Zhang L., Zhang T., Wang L., Shao S., Chen Z., Zhang Z. In vivo targeted delivery of CD40 shRNA to mouse intestinal dendritic cells by oral administration of recombinant Sacchromyces cerevisiae. Gene Ther. 2014, 21:709-714.
17. Kiflmariam M.G., Yang H., Zhang Z. Gene delivery to dendritic cells by orally administered recombinant Saccharomyces cerevisiae in mice. Vaccine 2013, 31:1360-1363.
18. Zhang T., Sun L., Xin Y., Ma L., Zhang Y., Wang X., et al. A vaccine grade of yeast Saccharomyces cerevisiae expressing mammalian myostatin. BMC Biotechnol. 2012, 12:97.
19. Zhang T., Yang H., Wang R., Xu K., Xin Y., Ren G., et al. Oral administration of myostatin-specific whole recombinant yeast Saccharomyces cerevisiae vaccine increases body weight and muscle composition in mice. Vaccine 2011, 29:8412-8416.
20. Allnutt F.C., Bowers R.M., Rowe C.G., Vakharia V.N., LaPatra S.E., Dhar A.K. Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast. Vaccine 2007, 25:4880-4888.
21. Gietz R.D. Yeast transformation by the LiAc/SS carrier DNA/PEG method. Methods Mol. Biol. 2014, 1205:1-12.
22. Zhang T., Lei J., Yang H., Xu K., Wang R., Zhang Z. An improved method for whole protein extraction from yeast Saccharomyces cerevisiae. Yeast 2011, 28:795-798.
23. Zhu B., Liu G.-L., Gong Y.-X., Ling F., Wang G.-X. Protective immunity of grass carp immunized with DNA vaccine encoding the vp7 gene of grass carp reovirus using carbon nanotubes as a carrier molecule. Fish. Shellfish Immunol. 2015, 42:325-334.
24. Xue R., Liu L., Cao G., Xu S., Li J., Zou Y., et al. Oral vaccination of BacFish-vp6 against grass carp reovirus evoking antibody response in grass carp. Fish. Shellfish Immunol. 2013, 34:348-355.
25. Stubbs A.C., Martin K.S., Coeshott C., Skaates S.V., Kuritzkes D.R., Bellgrau D., et al. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat. Med. 2001, 7:625-629.
26. Bazan S.B., Geginat G., Breinig T., Schmitt M.J., Breinig F. Uptake of various yeast genera by antigen-presenting cells and influence of subcellular antigen localization on the activation of ovalbumin-specific CD8 T lymphocytes. Vaccine 2011, 29:8165-8173.
27. Walch-Rückheim B., Schmitt M.J., Breinig F. Schizosaccharomyces pombe: a novel transport vehicle of functional DNA and mRNA into mammalian antigen-presenting cells. Vaccine 2014, 32:6029-6033.
28. Bassity E., Clark T.G. Functional identification of dendritic cells in the teleost model, rainbow trout (Oncorhynchus mykiss). PLoS One 2012, 7:e33196.
29. Wittamer V., Bertrand J.Y., Gutschow P.W., Traver D. Characterization of the mononuclear phagocyte system in zebrafish. Blood 2011, 117:7126-7135.
30. Lugo-Villarino G., Balla K.M., Stachura D.L., Banuelos K., Werneck M.B., Traver D. Identification of dendritic antigen-presenting cells in the zebrafish. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15850-15855.
31. Lokka G., Falk K., Austbo L., Koppang E.O. Uptake of yeast cells in the Atlantic salmon (Salmo salar L.) intestine. Dev. Comp. Immunol. 2014, 47:77-80.
32. Wi G.R., Hwang J.Y., Kwon M.G., Kim H.J., Kang H.A., Kim H.J. Protective immunity against nervous necrosis virus in convict grouper Epinephelus septemfasciatus following vaccination with virus-like particles produced in yeast Saccharomyces cerevisiae. Vet. Microbiol. 2015, 177:214-218.
33. Heppell J., Davis H.L. Application of DNA vaccine technology to aquaculture. Adv. Drug Deliv. Rev. 2000, 43:29-43.
34. Tsai H.-J., Kuo J.-C., Lou S.-W., Kuo T.-T. Articles: growth enhancement of juvenile striped mullet by feeding recombinant yeasts containing fish growth hormone. Progress. Fish Cult. 1994, 56:7-12.
35. Gannam A.L., Schrock R.M. Immunostimulants in fish diets. J. Appl. Aquac. 1999, 9:53-89.
36. Palm R.C., Landolt M.L., Busch R.A. Route of vaccine administration: effects on the specific humoral response in rainbow trout Oncorhynchus mykiss. Dis. Aquat. Org. 1998, 33:157-166.